General Information of Drug (ID: DMOG4TF)

Drug Name
SELA-212
Indication
Disease Entry ICD 11 Status REF
Gout FA25 Phase 2 [1]
Cross-matching ID
TTD ID
D0C8MG

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)